H. Shepard
Gründer bei Enosi Life Sciences Corp.
Aktive Positionen von H. Shepard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | 16.08.2018 | - |
Technik-/Wissenschafts-/F&E-Leiter | 16.08.2018 | - | |
Gründer | 16.08.2018 | - | |
Präsident | 16.08.2018 | - | |
Vorstandsvorsitzender | 16.08.2018 | 09.11.2021 |
Karriereverlauf von H. Shepard
Ehemalige bekannte Positionen von H. Shepard
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.06.2009 | 01.02.2017 |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Technik-/Wissenschafts-/F&E-Leiter | 27.05.2003 | 02.01.2008 |
Gründer | 27.05.2003 | 02.01.2008 | |
Präsident | 27.05.2003 | 02.01.2008 | |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 | 01.01.2008 |
Präsident | 01.01.1997 | 01.01.2008 | |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1992 | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.1980 | - |
NEVIS BRANDS INC. | Direktor/Vorstandsmitglied | 09.07.2020 | - |
Independent Dir/Board Member | 09.07.2020 | - |
Ausbildung von H. Shepard
Indiana University | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Kanada | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
President | 3 |
Founder | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA. | Health Technology |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021. | Health Technology |
- Börse
- Insiders
- H. Shepard
- Erfahrung